The goal of this activity is to improve the knowledge, competence, and performance of learners to optimize identification and treatment for patients with bipolar depression both with and without mixed features and anxious distress
With the expanding use of antipsychotic agents for the treatment of bipolar and major depressive disorder, awareness of the risk for tardive dyskinesia is vital in these patient populations. This session presents best pratices for screening, symptom assessment, and treatment…
Overview up-to-date evidence for safe and effective maintenance anti-mania therapies in bipolar I disorder, including lithium, mood stabilizers, and antipsychotic agents, with an eye toward optimizing patient engagement and treatment adherence.
Interact with case-based education on augmentation strategies for MDD, featuring treatment pathway decisions and evidence-based approaches for personalized care. Distinguish switching versus augmentation criteria with downloadable educational materials to reinforce practical application of pharmacology with patient-specific planning.
Enhance your clinical approach to managing bipolar depression by taking a deep dive into the complexities of mixed features and anxious distress, including their significant clinical implications for patient health. This session reviews evidence-based treatment strategies, with a focused look…
Safe use of antidepressant therapy during pregnancy and lactation is a recurrent topic in public discourse. This session reviews and evaluates published data with an eye toward methodological limitations to provide evidence-based guidance for the treatment of perinatal depression.
Safe use of antidepressant therapy during pregnancy and lactation is a recurrent topic in public discourse. This session reviews and evaluates published data with an eye toward methodological limitations to provide evidence-based guidance for the treatment of perinatal depression.
Shed light on seasonal affective disorder by strengthening your skills in its timely diagnosis and effective management. This program provides a comprehensive review of diagnostic criteria to distinguish SAD from other mood disorders and explores the evidence behind first-line interventions….
While there is an expanding toolbox of effective treatments for mood disorders, no treatment is without risks. This session covers rare, life-threatening reactions during treatment, focusing on neuroleptic malignant syndrome and serotonin syndrome. Best practices include careful monitoring informed by…
Many patients with mood disorders also have undiagnosed ADHD, increasing morbidity and likelihood of treatment failure. This session will explore the prevalence and impact of ADHD comorbidity with mood disorders and discuss best practices for assessment and symptom management in…
© 2025
American Board of Medical Specialties | Policies | Sitemap | Terms of Use | www.abms.org
